Hosoi Yuichiro, Kawakami Michiyuki, Ito Daisuke, Kamimoto Takayuki, Kamimura Hiroteru, Kawaguchi Takumi, Terai Shuji, Tsuji Tetsuya
Department of Rehabilitation Medicine, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University, 1-757, Asahimachi-dori, Chuo-ku, Niigata city, 951-8510, Japan.
BMC Gastroenterol. 2025 Apr 23;25(1):291. doi: 10.1186/s12876-025-03881-4.
This scoping review aimed to delineate the detailed components of exercise therapy and the evaluation methods used for patients with liver cirrhosis.
The methodology involved searching the original PubMed, Web of Science, and Scopus for studies published between January 1975 and March 2025. The search was completed on 13 March 2025. Studies describing exercise therapy for liver cirrhosis patients were selected. Relevant information matching the study objectives, such as intervention duration, content, intensity setting, evaluation criteria, and outcomes, was extracted and documented.
Of the 2314 articles identified, 18 fit the inclusion and exclusion criteria, with a total of 950 participants. The most prevalent form of exercise therapy was a combined aerobic exercise and strength training program (55.6%). Commonly used assessment criteria included the 6-minute walking distance for endurance evaluation (44.4%) and the Chronic Liver Disease Questionnaire for quality of life assessment (33.3%). Intervention durations ranged from 30 to 60 min per day, 2 to 7 days per week, and 8 to 12 weeks. Concerning intensity setting, subjective fatigue levels and heart rate were frequently used (38.9%), though detailed descriptions were limited.
For the establishment of effective exercise therapy for patients with liver cirrhosis, future research should concentrate on tailoring intensity settings according to individual patient needs. Additionally, standardized reporting of intervention details and assessment methods is crucial for improving the quality and comparability of studies in this field.
本范围综述旨在描述运动疗法的详细组成部分以及用于肝硬化患者的评估方法。
该方法包括在原始的PubMed、科学网和Scopus数据库中检索1975年1月至2025年3月发表的研究。检索于2025年3月13日完成。选取了描述肝硬化患者运动疗法的研究。提取并记录了与研究目标匹配的相关信息,如干预持续时间、内容、强度设置、评估标准和结果。
在确定的2314篇文章中,18篇符合纳入和排除标准,共有950名参与者。运动疗法最常见的形式是有氧运动和力量训练相结合的方案(55.6%)。常用的评估标准包括用于耐力评估的6分钟步行距离(44.4%)和用于生活质量评估的慢性肝病问卷(33.3%)。干预持续时间为每天30至60分钟,每周2至7天,共8至12周。关于强度设置,主观疲劳水平和心率经常被使用(38.9%),但详细描述有限。
为了为肝硬化患者建立有效的运动疗法,未来的研究应集中于根据个体患者需求调整强度设置。此外,干预细节和评估方法的标准化报告对于提高该领域研究的质量和可比性至关重要。